Please provide your email address to receive an email when new articles are posted on . In clinical ophthalmology, we are used to fixing problems on a physical or mechanical level. Jason I. Comander ...

Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.

Although rare diseases are individually rare, around the globe nearly 400 million people suffer from approximately 7,000 different rare diseases. Approximately 80% of all rare diseases are genetic in ...

A brain-machine interface company has investigated the problems found in today's intracranial implants and come to a game-changing conclusion: If the mountain won't come to them, then they'll have to ...

A combination of genes has been identified as a possible indicator of greater tissue destruction leading to negative outcomes for implants. A study of individuals with the combination of interleukin ...

Forbes contributors publish independent expert analyses and insights. The period between the 1920s and 1950s was a time of significant progress and exciting discoveries in gene therapy history and ...

Eleven years ago, gene therapy — where defective genes are snipped out of DNA and replaced with healthy ones — became a household name. A landmark paper proved that scientists could precisely ...

WASHINGTON (AP) — Australian researchers have combined cochlear implants with gene therapy in an experiment that improves the hearing of deafened animals. Cochlear implants partially restore hearing ...

TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a ...